SEC Filings TLDR

The filing details a securities sale plan for Katherine M. Borninkhof, an officer of AutoZone Inc. The plan involves the sale of 300 common shares acquired through an option granted on 05/10/2021. The shares are to be sold on 10/27/2025, with an aggregate market value of $1,132,500. The plan was adopted on 06/27/2025, ...

The filing details the securities transactions of Peter J. Federico, an officer and director of AGNC Investment Corp. On October 27, 2025, Federico plans to sell 45,798 shares of common stock acquired through restricted stock vesting on July 1, 2016. The aggregate market value of these shares is approximately $470,220....

Sarah Gheuens, an officer at Agios Pharmaceuticals, Inc., has exercised stock options for 3,302 shares of common stock on October 27, 2025. The stock options were originally granted on February 25, 2025. The transaction was executed at a market value of $145,027.80, with the shares being sold through Morgan Stanley Smi...

William Wood III, an officer of AGILYSYS INC, has filed a Form 144 notice indicating his intention to sell 6,000 shares of AGILYSYS INC common stock. The shares are held in a brokerage account with Fidelity Brokerage Services LLC and are planned to be sold on or around October 27, 2025. The aggregate market value of th...

Aviad Eyal, a director of monday.com Ltd., has filed a notice of planned sale of 8,332 common shares under a Rule 10b5-1(c) selling plan adopted on December 3, 2024. The shares were acquired from the issuer in a private transaction on January 1, 2018. The approximate sale date is October 24, 2025, with an aggregate mar...

Robert Schlossman, an officer at Zscaler, Inc., has filed a Form 144 with the SEC, indicating his intention to sell 3,200 shares of common stock acquired through Restricted Stock Units. The shares were acquired on September 15, 2022, and the planned sale is expected to occur around October 24, 2025, with an aggregate m...

The Yelp Foundation has filed a Form 144 with the SEC, indicating the sale of 2,500 shares of Yelp Inc. common stock. The shares were acquired on March 2, 2012, and were exercised as part of a cash transaction. The sale is scheduled for October 24, 2025, with an aggregate market value of $83,850.00. Additionally, the f...

Renae Gaudette, the COO of Winmark Corp., has filed a Form 144 with the SEC indicating her intention to sell 1,200 shares of Winmark Corp. common stock. The shares were acquired on October 23, 2025, as part of a restricted stock transaction. The approximate sale date is set for October 24, 2025, with an aggregate marke...

The filing details the securities transactions of James A. Burke, an officer and director of Vistra Corp. It includes the sale of 19,600 common shares on 10/24/2025, with an aggregate market value of $3,850,662.80. The filing also lists numerous transactions over the past three months, involving the sale of common shar...

Robert Gendron, an officer at Vicor Corporation, exercised stock options for 2,795 shares of common stock on October 24, 2025. The shares were acquired from the issuer, and the transaction was not a gift. Additionally, Gendron sold 2,116 shares of common stock on October 23, 2025, generating gross proceeds of $187,649....

Claudio Tuozzolo, an officer and director at Vicor Corporation, exercised stock options on October 24, 2025, acquiring 5,508 shares of common stock. The transaction was a cash payment, and the shares were acquired directly from the issuer. Additionally, Tuozzolo sold 14,637 shares of common stock on October 23, 2025, g...

Andrew Damico, a director at Vicor Corporation, has filed a Form 144 indicating his intention to sell 2,636 shares of common stock acquired through the exercise of stock options. The options were exercised on October 24, 2025, with the shares to be sold on the same date. The aggregate market value of these shares is ap...

Philip D. Davies, an officer of Vicor Corporation, has filed a Form 144 indicating his intent to sell 15,763 common shares of the company. The shares were acquired on August 14, 2024, through the exercise of previously held options. The approximate sale date is set for October 24, 2025, with an aggregate market value o...

Scott Darling, an officer at Upstart Holdings, Inc., has exercised stock options and sold shares in the company. On October 24, 2025, Darling exercised options to acquire 1,000 shares of common stock, which were subsequently sold on the same date for an aggregate market value of $55,012. This transaction was facilitate...

Martine Rothblatt, the Founder, Chairperson, and CEO of United Therapeutics Corp, has filed a notice of sale of common stock. The filing details the sale of 4,000 shares on October 24, 2025, with an aggregate market value of $1,696,259.60. Additionally, the filing discloses multiple sales of common stock over the past ...

The filing details the securities transactions of Amandine Robin-Caplan, an officer at TNL. On 08/25/2025, Robin-Caplan acquired 3,246 common shares through RSU vesting. Subsequently, on 10/24/2025, she sold 1,538 common shares for a total value of $100,016.14. The transactions were executed through Merrill Lynch on th...

The filing details the vesting of Restricted Stock Units (RSUs) and the sale of securities by Geoffrey Richards, an officer of Travel + Leisure Co. The RSUs vested on various dates from November 2018 to March 2024, with a total of 100,011 units sold on October 23, 2025, for an aggregate market value of $6,900,759. Addi...

Keelan Adamson, an officer of Transocean Ltd, has filed a Form 144 to sell 40,942 common shares acquired as Restricted Stock Units. The shares were acquired on March 1, 2024, and the sale is planned for October 24, 2025. The aggregate market value of the shares to be sold is approximately $159,264.38. The securities ar...

Brady Long, an officer of Transocean Ltd, has filed a notice to sell 97,090 shares of common stock acquired through restricted stock units. The securities were acquired between March 1, 2021, and February 10, 2022, and are planned to be sold on October 24, 2025. The aggregate market value of the shares is approximately...

Marc N. Casper, an officer and director of Thermo Fisher Scientific Inc., has filed a Form 144 indicating the intent to sell 17,104 shares of common stock acquired through an option granted on February 26, 2019. The shares are expected to be sold on October 24, 2025, with an aggregate market value of approximately $980...

The filing details the stock transactions of Gianluca Pettiti, an officer at Thermo Fisher Scientific Inc. Pettiti has acquired shares through restricted stock vesting on multiple dates: 87 shares on 02/28/2024, 125 shares on 05/05/2024, and 188 shares on 08/23/2024. Additionally, Pettiti sold 400 shares on 07/25/2025,...

The filing details the securities transactions of Michael D Dunn, an officer at Symbotic Inc. It includes the vesting of 2,228 Class A Common shares on October 23, 2025, under a registered plan. Additionally, the filing reports multiple sales of securities by Dunn over the past three months, totaling significant amount...

The filing details the securities transactions of Miriam Ort, an officer at Symbotic Inc. On October 23, 2025, Ort acquired 5,029 shares of common stock through restricted stock vesting under a registered plan. The aggregate market value of these shares is $338,659.87. Additionally, Ort sold securities in the past thre...

Maria G Freve, an officer of Symbotic Inc., has reported securities transactions involving the company's common stock. On October 23, 2025, Freve acquired 482 shares of restricted stock under a registered plan, with an aggregate market value of $33,004.95. Additionally, Freve sold 2,000 shares on August 18, 2025, for $...

Wayne DeVeydt, a former director of Surgery Partners, Inc., has filed a Form 144 notice indicating the sale of 2,913 common shares acquired through equity vesting on October 22, 2025. The aggregate market value of these shares is approximately $64,959.90. Additionally, DeVeydt has engaged in numerous securities transac...